Brief: Irlab Signs With Regulatory Consultants Ahead Of FDA Mesdopetam Meeting

IRLAB Therapeutics AB

10/10/2023 06:45

Oct 10 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * SIGNS PHASE III REGULATORY US CONSULTANTS TO SUPPORT
PREPARATION
FOR MESDOPETAM’S END-OF-PHASE 2 MEETING WITH THE US FDA
    * COMPANY HAS SECURED TOP EXPERTISE IN SUPPORTING
PREPARATIONS FOR
PHASE III WITH MESDOPETAM
    * COLLABORATION STARTS IMMEDIATELY WITH CLINTREX LEADING
IRLAB'S
US REGULATORY STRATEGY
    * PROPHARMA GROUP ACTING AS IRLAB'S REGULATORY US AGENT

Source text for Eikon:  ID:nMFN5yHpCY 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))